Table 1. DNA vaccine regimens in rhesus macaques.
Macaque | DNA Delivery | Priming Vaccine (number of vaccinations) | Heterologous DNA Boost |
L862 | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
M166 | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
M695 | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
R279 | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
R315a | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
P302a | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
P307a | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
P308a | IM/EP | p24CE1+p24CE2 (2×) | COT-M p55gag |
P314b , c | IM/EP | p24CE1+p24CE2 (3×) | COT-M p55gag |
M437b , c | IM/EP | p24CE1+p24CE2 (3×) | COT-M p55gag |
L863 | IM/EP | p24CE1+p24CE2+COT-M p55gag (3×) | none |
M629 | IM/EP | p24CE1+p24CE2+COT-M p55gag (3×) | none |
P572 | IM/EP | p24CE1+p24CE2+COT-M p55gag (3×) | none |
R285 | IM/EP | p24CE1+p24CE2+COT-M p55gag (3×) | none |
L985 | IM/EP | COT-M p55gag (2×) | p24CE1+p24CE2 |
P574 | IM/EP | COT-M p55gag (2×) | p24CE1+p24CE2 |
R067 | IM/EP | COT-M p55gag (2×) | p24CE1+p24CE2 |
R288 | IM/EP | COT-M p55gag (2×) | p24CE1+p24CE2 |
M085c | IM/EP | HXB2 p37gag (6×) | none |
M114c | IM/EP | HXB2 p37gag (6×) | none |
M121c | IM/EP | HXB2 p37gag (6×) | none |
3169c | IM | HXB2 p55gag (5×) | none |
3274c | IM | HXB2 p55gag (5×) | none |
3278c | IM | HXB2 p55gag (5×) | none |
3290c | IM | HXB2 p55gag (5×) | none |
Vaccine consists of a dual expression plasmid producing the p24CE1+p24CE2 antigens.
Received prior 3 vaccinations with the DNAs expressing the poorly immunogenic unmodified p24CE.
Vaccine did not include IL-12 DNA adjuvant.